SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mulanoon2007 who wrote (3965)11/3/2015 2:24:13 PM
From: tktom  Read Replies (1) of 4474
 
I'm quite surprised this isn't much lower in share price. Metrics were a disaster..Quarter over quarter US sales decline. It's as if there are no patients progressing and needing a third line compound. May be more short covering is holding it up? Marty is the ultimate spin Doctor with Iclusig sales metrics. The analysts are asking intelligent questions so they can model Ariad's prospects, but all Marty can say we can't reveal those
numbers (like # of patients still on the drug). I suppose that is why the coverage of Ariad is so sparse..
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News